RNAC · Cartesian Therapeutics, Inc. · Documents
$6.18
-0.23 (-3.59%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$186.98M
Shares
30.26M
Volume · Oct 23
85.9K
Avg daily vol (3M)
131.68K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-08-08 | — | |
| PRE 14A | — | 2024-08-02 | — | |
| S-1 | — | 2024-08-02 | — | |
| 8-K | — | 2024-07-02 | 2024-07-01 | |
| 8-K | — | 2024-06-17 | 2024-06-14 | |
| 8-K | — | 2024-05-22 | — | |
| 8-K | — | 2024-05-08 | — | |
| 10-Q | — | 2024-05-08 | 2024-03-31 | |
| DEF 14A | — | 2024-04-26 | 2023-12-31 | |
| DEFA14A | — | 2024-04-26 | — | |
| 8-K | — | 2024-04-22 | 2024-04-19 | |
| 8-K | — | 2024-04-09 | 2024-04-08 | |
| 8-K | — | 2024-04-01 | 2024-03-26 | |
| 8-K | — | 2024-03-28 | 2024-03-26 | |
| 8-K | — | 2024-03-14 | 2024-03-08 | |
| 10-K | — | 2024-03-07 | 2023-12-31 | |
| 8-K | — | 2024-03-07 | — | |
| 8-K | — | 2024-03-05 | 2024-02-28 | |
| DEFA14A | — | 2024-02-14 | — | |
| DEF 14A | — | 2024-02-14 | — | |
| PRE 14A | — | 2024-01-31 | — | |
| 8-K/A | — | 2024-01-23 | 2023-11-13 | |
| 8-K | — | 2024-01-19 | 2024-01-17 | |
| 8-K | — | 2024-01-08 | — | |
| S-3/A | — | 2023-12-01 | — | |
| 8-K | — | 2023-11-27 | 2023-11-21 | |
| DEFA14A | — | 2023-11-13 | — | |
| 10-Q | — | 2023-11-13 | 2023-09-30 | |
| 8-K | — | 2023-11-13 | — | |
| 8-K | — | 2023-10-31 | — | |
| S-3 | — | 2023-10-25 | — | |
| 8-K | — | 2023-09-25 | 2023-08-25 | |
| 8-K | — | 2023-09-13 | 2023-09-11 | |
| 10-Q | — | 2023-08-17 | 2023-06-30 | |
| 8-K | — | 2023-08-17 | — | |
| NT 10-Q | — | 2023-08-14 | 2023-06-30 | |
| 8-K | — | 2023-06-16 | — | |
| DEFA14A | — | 2023-06-13 | — | |
| 10-Q | — | 2023-05-04 | 2023-03-31 | |
| DEFA14A | — | 2023-04-28 | — | |
| DEF 14A | — | 2023-04-28 | — | |
| PRE 14A | — | 2023-04-18 | — | |
| 8-K | — | 2023-04-04 | 2023-03-31 | |
| 8-K | — | 2023-03-21 | — | |
| 10-K | — | 2023-03-02 | 2022-12-31 | |
| 8-K | — | 2023-01-09 | 2023-01-04 | |
| 8-K | — | 2022-12-14 | — | |
| 8-K | — | 2022-11-28 | 2022-11-22 | |
| 8-K | — | 2022-11-18 | — | |
| 10-Q | — | 2022-11-03 | 2022-09-30 |
Showing 51–100 of 177 filings
Key facts
CIK
1453687
CUSIP
816212302
13F (30d)
12 filings
12 filers
Visit website
Investor relations